Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RVTY✓SelectedUSD · RVTYGSK vs RVTY performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs RVTY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
RVTY return
+208.1%
Excess return
-105.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRVTYExcessAlpha
1D-1.3%+3.1%-4.5%-1.9%
7D-3.1%-3.7%+0.6%-2.5%
30D-0.9%+1.0%-1.9%-1.4%
3M-4.2%+34.1%-38.2%-9.8%
6M-1.6%+59.8%-61.4%-10.8%
YTD+2.6%+57.9%-55.3%-7.4%
1Y+6.2%+64.2%-58.0%-4.9%
3Y+55.0%+74.6%-19.7%+34.3%
5Y+42.8%-17.6%+60.5%+42.6%
10Y+102.1%+213.8%-111.7%+41.1%
All+102.1%+208.1%-105.9%+41.1%

Cumulative growth

Daily Returns

Daily percentage return beside RVTY.

Daily Out/Under-Performance

Portfolio return minus RVTY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RVTY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RVTY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling